STOCK TITAN

Adara Acquisition Corp. Announces Closing of $115 Million Initial Public Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

Adara Acquisition Corp. has successfully closed its initial public offering, raising $115 million by selling 11.5 million units at $10 each, including an additional 1.5 million units from an over-allotment option. The units are listed on NYSE American under the ticker symbol 'ADRA.U'. The company, sponsored by cbdMD, Inc. and Blystone & Donaldson, aims to identify potential merger or acquisition targets in the consumer products sector. Each unit includes one share of Class A common stock and half a warrant to purchase additional shares at $11.50 each.

Positive
  • Total gross proceeds of $115 million from the IPO offer significant capital for future business combinations.
  • Strategic sponsorship by cbdMD, Inc. may enhance credibility and market reach.
Negative
  • The reliance on future business combinations poses inherent market risks.
  • Investors may face dilution from the exercise of warrants at $11.50 per share.

Adara Acquisition Corp. (the “Company”), a newly incorporated blank check company, today announced that it closed its initial public offering of 11,500,000 units, including 1,500,000 sold pursuant to the full exercise of the underwriters’ over-allotment option, at $10.00 per unit. Total gross proceeds from the offering were $115,000,000, before deducting underwriting discounts and commissions and other offering expenses. The Company’s units are listed on the NYSE American stock exchange (“NYSE American”) and began trading under the ticker symbol “ADRA.U” on February 9, 2021.

The Company’s sponsor, Adara Sponsor LLC, is led by cbdMD, Inc. (NYSE American: YCBD, YCBDpA) and Blystone & Donaldson, LLC.

The Company is led by its Chairman, Thomas Finke (former Chairman and CEO of Barings LLC), its CEO and director, Martin A. Sumichrast (Co-CEO of cbdMD, Inc.), and its director, W. Tom Donaldson (founder of Blystone & Donaldson). In addition to Messrs. Finke, Sumichrast and Donaldson, the Company’s Board of Directors also includes Frank Quintero, Dylan Glenn and Beatriz Acevedo-Greiff.

Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, shares of the Class A common stock and warrants are expected to be listed on the NYSE American under the symbols “ADRA” and “ADRA.WS,” respectively. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry, it currently intends to concentrate its search for a target business operating in the consumer products and related industries.

ThinkEquity, a division of Fordham Financial Management, Inc., acted as sole book-running manager.

The offering is being made only by means of a prospectus, copies of which may be obtained by contacting ThinkEquity, a division of Fordham Financial Management, Inc., 17 State Street, 22nd Floor, New York, New York 10004, by telephone at (877) 436-3673 or by email at prospectus@think-equity.com.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on February 8, 2021. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the initial public offering. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

FAQ

What is the total amount raised in Adara Acquisition Corp.'s IPO?

Adara Acquisition Corp. raised a total of $115 million in its IPO.

When did Adara Acquisition Corp. start trading on the stock exchange?

Adara Acquisition Corp. began trading on the NYSE American under the ticker 'ADRA.U' on February 9, 2021.

Who are the sponsors of Adara Acquisition Corp.?

The sponsors of Adara Acquisition Corp. include cbdMD, Inc. and Blystone & Donaldson, LLC.

What does each unit in Adara Acquisition Corp.'s IPO consist of?

Each unit consists of one share of Class A common stock and half of a redeemable warrant.

What is the exercise price for the warrants included in Adara Acquisition Corp.'s units?

The warrants included in each unit can be exercised at a price of $11.50 per share.

cbdMD, Inc.

NYSE:YCBD

YCBD Rankings

YCBD Latest News

YCBD Stock Data

1.77M
3.04M
19.14%
3.95%
7.46%
Drug Manufacturers - Specialty & Generic
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States of America
CHARLOTTE